ArticleCancer immunology, immunotherapy : CII2018

CXCL13 expression is prognostic and predictive for postoperative adjuvant chemotherapy benefit in patients with gastric cancer.

Yichou Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.